New #JITC short report: Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab https://t.co/4RbXbWyfEg @LandonBrownMD @brian_rini @TiansterZhang

Our recent work led by @LandonBrownMD published today in @CCR_AACR showing clinical prognostic utility of a CTC genomic instability and NEPC phenotype in men with mCRPC https://t.co/2mhVU4FgjJ$ @DukeGUCancer @Daniel_J_George @EpicSciences @EAntonarakis

@TheRealJasonZhu @Tucker_MatthewD @EAntonarakis @ramsedhom @AlvaAjjai @TiansterZhang @ChesterKao1 @MattLabsMD @Daniel_J_George @MRHarrisonMD @DukeCancer

We are excited to share our paper on pathogenic LRP1b mutations and outcomes with immunotherapy across multiple tumor types! Great collaborative effort between @DukeGUCancer @UMRogelCancer @hopkinskimmel led by @AarmstrongDuke https://t.co/4Ij6Os4Qvs

Great research and mentorship for @DukeFellows @DukeGUCancer @MattLabsMD @hannahdzmd

Excited to present the phase 2 PICK study led by @AarmstrongDuke at #GU21 Poster 89 - avelumab in neuroendocrine and agg variant #PCa ORR 7% (1/15) - one CR in a pt with MSI-H Limited efficacy of ICI alone in this aggressive dz Future trials to consider chemo+dual ICI

Thanks @montypal for highlighting our practical comparison between PD-L1 assays in #kidneycancer and #bladdercancer tissue! Good collaborative effort with our colleagues Drs. Shannon McCall, Wen-Chi Foo, & Jiaoti Huang @DukePathDept @DukeGUCancer

We lost an incredible teacher, mentor, role model, and friend-Dr. Neil Spector. He was the type of attending who would sit for hours after clinic to talk about science, medicine, careers, and life with the hem/onc fellows. We will miss you dearly, Dr. Spector!

@DrJessDeLaune @ASCO 1⃣ Program: @DukeCancer 2⃣ Why Duke: @DukeFellows Fam❗️Mentorship, Training tailored to career goals, ⬆️academic/research 🕰 3⃣ Why Durham: food, microbrews, lush trails, nearby 🏖&🏔 4⃣ Duke fellows:@amilliga @LandonBrownMD @hannahdzmd @MattLabs831 @candace_haddox 5⃣ DM OK? ✅

Check out our #ASCO2020 oral abstract! A great collaboration across institutions and a testament to the amazing mentorship @DukeGUCancer has for residents and fellows @Tucker_MatthewD @TheRealJasonZhu @MattLabs831 @AarmstrongDuke @DukeFellows @DukeIMChiefs

Here is our two part series on AR-7 now published @pcan_journal https://t.co/VbTaKYiww9 and https://t.co/pjfEXh6CkH @EAntonarakis @LandonBrownMD @DukeGUCancer

Dr Ali Brown, CA3, presenting at #SPABAH20 on Opioid Prescribing and Utilization Patterns for Outpatient Surgery in Children. @Duke_Anesthesia @PediAnesthesia @PedsPainMed

It was a privilege to work on this review of AR-V7 in prostate cancer with @AarmstrongDuke, @EAntonarakis, Dr. Luo, and Dr. Lu. It's an exciting time for novel biomarkers, but still lots of work to be done! https://t.co/ePjVBv2ODH

Honored to have been given this opportunity to share our work with this support! Looking forward to further investigation into clinically relevant prognostic and (hopefully!) predictive biomarkers across GU malignancies. #GU20 @DukeGUCancer @AarmstrongDuke @TiansterZhang

Excited to present this work with my amazing mentor @AarmstrongDuke. Thanks also to the support from an @ASCO merit award. #GU20

@DukeGUCancer @dukemedicine fellow @LandonBrownMD presenting the chromosome instability and neuroendocrine CTC features data from the #PROPHECY trial. Come by his poster #H19! #GU20 #oncoalert

@TiansterZhang delivering a great first @dukemedicine Grand Rounds of the decade on RCC! @DukeGUCancer @Daniel_J_George

So proud of our @IMResidencyDuke Chester Kao and @DukeCancer fellow Emily Kinsey, showing our #kidneycancer patients treated w ipi-nivo, highlights Cabo-nivo and immunotherapy discontinuation pts! @DukeGUCancer @sitcancer #SITC2019

Honored to take up a pen alongside inspiring colleague @fumikochino to tell her story of #financialtoxicity in this graphic op-ed for the @latimes . Stories of crushing #medicaldebt like this cannot be our normal. #graphicmedicine https://t.co/oeyXuwTesg

Congratulations to our own Dr. Alison Brown, current Duke Anesthesiology chief resident, on becoming THE FIRST anesthesia resident to be appointed as co-chair of the Duke Graduate Medical Education Patient Safety and Quality Council!